Farallon Capital Management’s Signify Health, Inc. SGFY Stock Holding History

Farallon Capital Management’s Portfolio SGFY Stock Details SGFY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,950,000	Closed	-$113M	–	215
2022 Q4	$113M	Buy	3,950,000 +3,600,000	+1,029%	+$104M	0.67%	46
2022 Q3	$10.2M	Buy	+350,000	New	+$8.06M	0.06%	131
2021 Q2	–	Sell	-100,000	Closed	-$2.93M	–	336
2021 Q1	$2.93M	Buy	+100,000	New	+$3.09M	0.01%	209

Other funds holding SGFY

BHCM

Brevan Howard Capital Management St. Helier, Jersey $11.3B AUM 35.84% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Farallon Capital Management's SGFY Position: Q1 2023 in Review

Farallon Capital Management sold out of Signify Health, Inc. (SGFY) in Q1 2023, closing a stake of 3,950,000 shares — an estimated $113M sold.

Farallon Capital Management first reported a position in SGFY in Q1 2021 and held it in 3 quarters. The position peaked at $113M in Q4 2022. 5 funds tracked by Wall St. Rank hold SGFY as of Q1 2023.

Farallon Capital Management reported no remaining Signify Health, Inc. position as of Q1 2023 after selling out during the quarter.
Farallon Capital Management sold 3,950,000 Signify Health, Inc. shares in Q1 2023, an estimated $113M.
Farallon Capital Management first reported a position in Signify Health, Inc. in Q1 2021 and held it in 3 quarters.
Farallon Capital Management's Signify Health, Inc. position peaked at $113M in Q4 2022.
5 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q1 2023.

Based on Farallon Capital Management's 13F filing for Q1 2023, filed 15 May 2023.